Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 2.257
Filter
1.
Asian Pac J Cancer Prev ; 25(8): 2751-2760, 2024 Aug 01.
Article in English | MEDLINE | ID: mdl-39205573

ABSTRACT

BACKGROUND: Anti-tobacco mass-media campaigns are an integral part of tobacco control. There is still a need to understand which mode of mass-media channels aids in promoting tobacco cessation. This study aimed to examine if exposure to anti-tobacco messages delivered through different media channels is associated with tobacco user's thoughts and attempts to quit. METHODS: We selected a sample of tobacco users (N=21857) from the Global Adult Tobacco Survey (GATS-2), and assessed the association of noticing the anti-tobacco information through different media channels with tobacco user's thoughts and attempts to quit. RESULTS: Males reported noticing anti-tobacco information more than females in almost all modes of media channels. Among males, the odds were significant and were highest with exposure to radio (1.78 (1.4-2.27)), and internet (1.68 (1.12-2.52)) for thoughts to quit smoking and to radio (2.17 (1.63-2.89) and newspaper (1.46 (1.2-1.79) for thoughts to quitting smokeless tobacco (SLT). The attempt to quit smoking and SLT use among males was significant for exposure through public transportation (1.22 (1.03-1.44)), public walls (1.44 (1.21-1.71), internet (1.68 (1.06-2.66)), and radio (1.44 (1.1-1.87)). Exposure to more than two media resulted in a higher likelihood of thoughts of quitting tobacco, and those exposed to more than one media attempted to quit tobacco among males. Females reported no influence from the media exposure. CONCLUSION: The study underscores the importance of targeted and combination of different mass-media channels to maximize the quit behaviors among male tobacco users. The current study also highlights the need for future studies to identify effective ways to communicate anti-tobacco information to women and all socio-economic groups in the country.


Subject(s)
Mass Media , Smoking Cessation , Humans , Male , Female , Adult , India/epidemiology , Mass Media/statistics & numerical data , Smoking Cessation/psychology , Smoking Cessation/methods , Surveys and Questionnaires , Middle Aged , Young Adult , Adolescent , Health Promotion/methods , Follow-Up Studies , Tobacco Use Disorder/prevention & control , Tobacco Use Disorder/epidemiology , Tobacco Use Disorder/psychology , Tobacco Use/prevention & control
4.
PLoS One ; 19(3): e0299728, 2024.
Article in English | MEDLINE | ID: mdl-38466736

ABSTRACT

Understanding the factors that influence smoking cessation among young people is crucial for planning targeted cessation approaches. The objective of this review was to comprehensively summarize evidence for predictors of different smoking cessation related behaviors among young people from currently available systematic reviews. We searched six databases and reference lists of the included articles for studies published up to October 20, 2023. All systematic reviews summarizing predictors of intention to quit smoking, quit attempts, or smoking abstinence among people aged 10-35 years were included. We excluded reviews on effectiveness of smoking cessation intervention; smoking prevention and other smoking behaviors; cessation of other tobacco products use, dual use, and polysubstance use. We categorized the identified predictors into 5 different categories for 3 overlapping age groups. JBI critical appraisal tool and GRADE-CERqual approach were used for quality and certainty assessment respectively. A total of 11 systematic reviews were included in this study; all summarized predictors of smoking abstinence/quit attempts and two also identified predictors of intention to quit smoking. Seven reviews had satisfactory critical appraisal score and there was minimal overlapping between the reviews. We found 4 'possible' predictors of intention to quit smoking and 119 predictors of smoking abstinence/quit attempts. Most of these 119 predictors were applicable for ~10-29 years age group. We had moderate confidence on the 'probable', 'possible', 'insufficient evidence', and 'inconsistent direction' predictors and low confidence on the 'probably unrelated' factors. The 'probable' predictors include a wide variety of socio-demographic factors, nicotine dependence, mental health, attitudes, behavioral and psychological factors, peer and family related factors, and jurisdictional policies. These predictors can guide improvement of existing smoking cessation interventions or planning of new targeted intervention programs. Other predictors as well as predictors of intention to quit smoking need to be further investigated among adolescents and young adults separately.


Subject(s)
Smoking Cessation , Tobacco Use Disorder , Adolescent , Young Adult , Humans , Child , Adult , Smoking Cessation/psychology , Systematic Reviews as Topic , Smoking , Tobacco Use Disorder/prevention & control , Tobacco Smoking , Smoking Prevention
5.
Transl Behav Med ; 14(4): 241-248, 2024 Mar 21.
Article in English | MEDLINE | ID: mdl-38330454

ABSTRACT

Multilevel interventions in healthcare settings (e.g. Ask, Advise, and Connect; AAC) can reduce tobacco product use among adult patients: their effectiveness in pediatric practice is largely unknown. We implemented an AAC model in pediatric primary care to deter children's tobacco use, and evaluated its effectiveness in a single-arm trial. At wellness visits, young patients (ages 12-17) completed a tablet-based assessment (Ask) of lifetime and current tobacco use. These data were made available within the electronic health record to pediatric primary care providers for preventive counseling (Advise). Providers then referred patients to an e-health evidence-based tobacco control intervention (Connect). Tobacco control outcomes were examined in the clinic population (N = 2219) and in a sample of patients (N = 388, 62% female, 39% non-White, M age = 15) over time, along with intervention engagement. Population use of tobacco products decreased following introduction of AAC (more than 2-fold). At the patient level, most children (80.9%) engaged with the intervention: those who were Black or African American, who never used tobacco products/were not susceptible to use, and who used fewer non-cigarette tobacco products were more likely to engage, but only after multiple prompts versus a single prompt. Engagement was positively associated with lowering children's susceptibility to using tobacco at follow-up. A pediatric AAC model holds promise in deterring youth tobacco use, including among historically marginalized populations who may require additional support.


By implementing a multilevel Ask, Advise, and Connect intervention, pediatric tobacco use declined in a clinical population, with high intervention engagement and improved outcomes.


Subject(s)
Smoking Cessation , Tobacco Control , Tobacco Use Disorder , Adolescent , Child , Female , Humans , Male , Counseling , Primary Health Care , Smoking Cessation/psychology , Tobacco Use Disorder/prevention & control
6.
Pneumologie ; 78(8): 561-565, 2024 Aug.
Article in German | MEDLINE | ID: mdl-38266746

ABSTRACT

E-cigarettes are used in clinical trials to facilitate smoking cessation. Due to the health risks associated with the use of e-cigarettes, the results of clinical trials should be fully reported, including continued exclusive use and dual use of tobacco and e-cigarettes. Nicotine cessation outcomes should be reported as the primary endpoint as well as the analysis of tobacco cessation alone. As there is currently no robust evidence that reducing cigarette consumption provides substantial health benefits, cigarette consumption reduction should not be used as a health outcome in clinical trials. Continued nicotine dependence should be included as an "adverse event" in the reporting of trial results.


Subject(s)
Electronic Nicotine Delivery Systems , Smoking Cessation , Humans , Clinical Trials as Topic , Evidence-Based Medicine , Germany , Smoking Cessation/methods , Tobacco Use Disorder/prevention & control , Treatment Outcome , Vaping/adverse effects
8.
Evid Based Dent ; 24(4): 159-160, 2023 12.
Article in English | MEDLINE | ID: mdl-37857806

ABSTRACT

DESIGN: Narrative review. REVIEW QUESTION: What are the implications of new nicotine and tobacco products on adolescent health? PRODUCTS: E-cigarettes and oral nicotine products such as pouches, lozenges, tablets, gum, and gummies. RESULTS: These products can be addictive and can cause respiratory, cardiovascular and oral potential health problems. They also have effects on brain development. Products are attractive to adolescents, with more than 1:10 American adolescents uses them. CONCLUSIONS: The use of nicotine and tobacco products by adolescents puts their health at risk and may, in some instances, lead to nicotine addiction. Those providing healthcare for adolescents have an opportunity to provide advice and signpost people to resources to help them stop using such products. There is also a need for legislation to restrict the sale of e-cigarettes and tobacco products.


Subject(s)
Electronic Nicotine Delivery Systems , Tobacco Products , Tobacco Use Disorder , Adolescent , Humans , Nicotine/adverse effects , Tablets , Tobacco Products/adverse effects , Tobacco Use Disorder/prevention & control
11.
Curr Opin Pediatr ; 35(4): 513-521, 2023 08 01.
Article in English | MEDLINE | ID: mdl-37335268

ABSTRACT

PURPOSE OF REVIEW: New nicotine and tobacco products such as electronic cigarettes and oral nicotine products have increased in use and threaten to addict a new generation of youth. This review summarizes current literature on nicotine and tobacco products used by youth, epidemiology, health effects, prevention and treatment of nicotine dependence, and current policies and regulations. RECENT FINDINGS: Electronic cigarettes and oral nicotine products are popular among youth, attracting adolescents through exposure to deceptive marketing and fruit, candy and dessert flavors. Electronic cigarettes and oral nicotine product use can lead to nicotine addiction and is associated with respiratory, cardiovascular, and oral health problems, although long-term health effects are not fully known. The Food and Drug Administration (FDA) has authority to regulate nicotine and tobacco products; however, thousands of unregulated and unauthorized products remain on the market. SUMMARY: Millions of adolescents continue to use nicotine and tobacco products, which puts them at risk for health problems, including nicotine addiction. Pediatric providers can provide prevention messages, screen youth for tobacco and nicotine use, and offer appropriate treatment options. Regulation of tobacco and nicotine products by the FDA is critical to reverse this public health epidemic of youth nicotine and tobacco use.


Subject(s)
Electronic Nicotine Delivery Systems , Tobacco Use Disorder , Adolescent , Humans , Child , Nicotine/adverse effects , Tobacco Use Disorder/epidemiology , Tobacco Use Disorder/prevention & control , Smoking/epidemiology
13.
J Adolesc Health ; 72(3): 359-364, 2023 03.
Article in English | MEDLINE | ID: mdl-36476393

ABSTRACT

PURPOSE: This paper determines the association between youth e-cigarette use "to try to quit using other tobacco products, such as cigarettes" and having stopped smoking cigarettes (defined as an ever cigarette smoker who did not smoke in the past 30 days). METHODS: This study uses data from the NYTS from 2015 through 2021, focusing on youth who started smoking cigarettes before they started using e-cigarettes. Associations between using e-cigarettes to quit and having stopped smoking were computed using logistic regression accounting for the complex survey design and adjusting for level of nicotine dependence, year, age, gender, and race/ethnicity. Sensitivity analyses allowed for having started cigarettes and e-cigarettes in the same year and without regard for starting sequence. RESULTS: The primary analytic subsample included 6435 United States middle and high school students (mean age 15.9 years, 55.4% male). Using e-cigarettes to quit was associated with significantly lower odds of having stopped smoking cigarettes (odds ratio, 0.62; 95% confidence interval, 0.45-0.85), controlling for nicotine dependence and demographics. Youth with higher levels of nicotine dependence also had lower odds of having stopped smoking. The results were stable over time. Sensitivity analyses produced similar results. DISCUSSION: Ever-smoking youth who used e-cigarettes "to try to quit using other tobacco products, such as cigarettes" had lower odds of having stopped smoking cigarettes than those who did not use e-cigarettes as to try to quit. Physicians, regulators, and educators should discourage youth from attempting to use e-cigarettes as a way to stop smoking cigarettes.


Subject(s)
Electronic Nicotine Delivery Systems , Smoking Cessation , Tobacco Products , Tobacco Use Disorder , Adolescent , Male , Humans , United States , Female , Nicotiana , Cross-Sectional Studies , Tobacco Use Disorder/prevention & control , Smoking
14.
Nicotine Tob Res ; 25(3): 372-378, 2023 02 09.
Article in English | MEDLINE | ID: mdl-35752091

ABSTRACT

INTRODUCTION: How nicotine dependence will be affected when current smokers initiate electronic cigarette (e-cigarette) use to reduce cigarette smoking is unknown. This study evaluated cigarette, e-cigarette, and total nicotine dependence more than 6 months among smokers reducing cigarette consumption by replacing with e-cigarettes. AIMS AND METHODS: Adult cigarette smokers were randomized to one of four conditions (36 mg/ml e-cigarette, 8 mg/ml e-cigarette, 0 mg/ml e-cigarette, or cigarette-substitute [CS] [provided at no cost]) and instructed to reduce their cigarette smoking by 75% at 1 month. Participants completed follow-up at 1, 3, and 6 months. The Penn State Nicotine Dependence Index (PSNDI) measured dependence on cigarettes (PSCDI) and e-cigarettes (PSECDI). Urine cotinine measured total nicotine exposure. Linear mixed effects models for each outcome were conducted and included interaction terms between visit and condition. RESULTS: Participants (n = 520) were 58.8% female, 67.3% White, and 48.0 years old. At baseline, the median number of cigarettes smoked per day was 17.3 and the mean PSCDI score was 13.4, with no significant differences between conditions. Participants in the e-cigarette conditions reported significantly lower PSCDI scores, compared with baseline, and with the CS condition at all follow-up visits. Those in the 36 mg/ml e-cigarette condition reported greater PSECDI scores at 6 months, compared with baseline and the 0 mg/ml and 8 mg/ml conditions. At all follow-up visits, there were no differences in total nicotine exposure compared to baseline, nor between any conditions. CONCLUSIONS: E-cigarette use was associated with reduced cigarette dependence, compared to the CS, without significant increases in total nicotine exposure. IMPLICATIONS: Initiation of electronic cigarette use while continuing to smoke could potentially increase nicotine dependence. In this randomized trial aimed at helping smokers to reduce their cigarette intake, we found that use of an e-cigarette was associated with a reduction in cigarette dependence and an increase in e-cigarette dependence (in the condition with the highest nicotine concentration only), with no long term increase in total nicotine dependence or nicotine exposure.


Subject(s)
Cigarette Smoking , Electronic Nicotine Delivery Systems , Smoking Cessation , Tobacco Products , Tobacco Use Disorder , Adult , Humans , Female , Male , Tobacco Use Disorder/prevention & control , Nicotine , Smokers , Nicotiana
16.
Evid. actual. práct. ambul ; 26(4): e007050, 2023. ilus, tab
Article in Spanish | LILACS, UNISALUD, BINACIS | ID: biblio-1526396

ABSTRACT

Introducción. El consumo de tabaco representa un importante desafío para la salud pública debido a su alta incidencia y mortalidad, y es el principal factor de riesgo modificable para desarrollar enfermedades crónicas no transmisibles. La Residencia de Medicina General y Familiar del Hospital General de Agudos Dr. Teodoro Álvarez desarrolló un programa de cesación tabáquica en el Centro de Salud y Acción Comunitaria N◦34, que forma parte desde 2012 del Programa de Prevención y Control del Tabaquismo del Ministerio de Salud del Gobierno de la Ciudad de Buenos Aires, Argentina. Objetivo. Documentar los resultados de la eficacia de este programa y explorar las variables relacionadas con la probabilidad de éxito y recaída. Materiales y métodos. Estudio cuantitativo, de corte transversal analítico, con datos obtenidos de historias clínicas electrónicas entre 2017 y 2020. Fueron incluidos los pacientes que consultaron al menos en dos ocasiones al programa de cesación tabáquica y establecieron un día D al menos 30 días antes del abandono del consumo de tabaco. La eficacia terapéutica fue definida como haber permanecido al menos seis meses sin fumar, y la recaída, como el reinicio de consumo del tabaco luego de haber logrado 24 horas de abstinencia con fecha posterior al día D.Resultados.De 59 pacientes, 24 (40,7 %) lograron la eficacia terapéutica, de los cuales 5 (20,8 %) presentaron recaídas.De los 35 pacientes que no lograron alcanzar la etapa de mantenimiento, 30 (85,7 %) recayeron durante las primeras ocho semanas. El sexo masculino y el consumo de tabaco superior a 20 paquetes-año mostraron una mayor correlación con las recaídas. Conclusiones. El programa presentó una eficacia terapéutica del 40,7 % en el periodo evaluado. Se encontraron asociaciones entre una mayor eficacia terapéutica y ciertas características de los pacientes, pero se requieren más estudios para confirmar esta hipótesis. (AU)


Background. Tobacco consumption represents an important challenge for public health due to its high incidence and mortality and is the main modifiable risk factor for developing chronic non-communicable diseases. The General and Family Medicine Residence of the Hospital General de Agudos Dr. Teodoro Álvarez developed a smoking cessation program in Health and Community Action Centre N◦34. Since 2012 it has been part of the Program for the Prevention and Control of Smoking of the Ministry of Health of the Government of Buenos Aires, Argentina. Objective. To document the results of the effectiveness of the program and explore the variables related to the probability of success and relapse. Materials and methods. Quantitative, analytical cross-sectional study, with data obtained from electronic medical records between 2017 and 2020. Patients who consulted the smoking cessation program at least twice and established a D-day 30 days before quitting tobacco consumption were included. Therapeutic efficacy was defined as having remained at least six months without smoking, and relapse, as the resumption of tobacco consumption after having achieved 24 hours of abstinence with a date after day D. Results. Of 59 patients, 24 (40.7 %) achieved therapeutic efficacy, of which 5 (20.8 %) presented relapses. Among the35 patients who failed to reach the maintenance stage, 30 (85.7 %) relapsed during the first eight weeks. Male sex and tobacco consumption of more than 20 pack per year showed a greater correlation with relapses. Conclusions.The program presented a therapeutic efficacy of 40.7 % in the evaluated period. Associations were found between greater therapeutic efficacy and certain patient characteristics but more studies are required to confirm this hypothesis. (AU)


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , Young Adult , Tobacco Use Disorder/therapy , Treatment Outcome , Smoking Cessation/methods , Tobacco Use Cessation/methods , Recurrence , Tobacco Use Disorder/prevention & control , Evaluation of Results of Therapeutic Interventions , Cross-Sectional Studies , Data Interpretation, Statistical , Smoking Cessation/statistics & numerical data , Tobacco Use Cessation/statistics & numerical data , Tobacco Control
17.
Prague; Ministry of Health; Dec. 14, 2022. 124 p. tab.
Non-conventional in Czech | BIGG | ID: biblio-1452154

ABSTRACT

Cílem tohoto klinického doporuceného postupu (KDP) je zarazení lécby závislosti na tabáku do bezné praxe vsech klinických oboru medicíny, jako je tomu v jiných zemích. Tento KDP se zabývá souvislostmi kourení v rámci hlavních klinických oboru, podstatou vzniku závislosti na tabáku, diagnostikou a lécbou vcetne aktuálních mozností v CR. Podle 10. verze Mezinárodní klasifikace nemocí Svetové zdravotnické organizace je závislost na tabáku (ZNT) nemocí, tj. diagnóza F17.X "Poruchy dusevní a poruchy chování zpusobené uzíváním tabáku". V CR se týká necelých dvou milionu obyvatel, tedy napr. dvakrát víc nez diabetiku. Je prícinou sestiny vsech úmrtí a ovlivnuje vznik, prubeh i lécbu naprosté vetsiny dalsích nemocí. Lécba závislosti na tabáku je tedy zároven prevencí mnoha dalsích nemocí.


The goal of this Clinical Guideline (KDP) is to include the treatment of tobacco dependence in the routine practice of all clinical branches of medicine, as is the case in other countries. This KDP deals with the context of smoking within the main clinical fields, the origin of tobacco addiction, diagnosis and treatment, including current options in the Czech Republic. According to the 10th version of the International Classification of Diseases of the World Health Organization, tobacco dependence (TCD) is a disease, i.e. diagnosis F17.X "Mental and behavioral disorders due to tobacco use". In the Czech Republic, it affects less than two million inhabitants, i.e. twice as many as diabetics. It is the cause of a sixth of all deaths and affects the origin, course and treatment of the vast majority of other diseases. The treatment of tobacco addiction is therefore also the prevention of many other diseases.


Subject(s)
Humans , Tobacco Use Disorder/prevention & control , Smoking Cessation , Czech Republic
18.
Cancer Control ; 29: 10732748221138713, 2022.
Article in English | MEDLINE | ID: mdl-36373741

ABSTRACT

Tobacco use accounts for 30% of all cancer-related deaths worldwide and 20% in the US, despite effective, evidence-based interventions for reducing tobacco use and tobacco-related cancers and deaths. In 2012, to reduce the burden of tobacco-related cancer and associated population-level risks across Texas, The University of Texas MD Anderson Cancer Center initiated the EndTobacco® program to promote statewide cancer control activities. We created evidence-based initiatives, established selection criteria, and implemented actions involving policy, education, and tobacco treatment services. As a result, EndTobacco has supported, educated, and convened local and state coalitions in policymaking; provided tobacco treatment education to health professionals; implemented Texas' only certified tobacco treatment training program; and led an initiative to enhance the tobacco-free culture of the state's publicly funded university system. Supported by commitments from MD Anderson, we developed and implemented evidence-based actions for tobacco control tailored to the center's mission, values, expertise, resources, and partnerships. By 2021, the adult smoking rate in Texas dropped from 19.2% (2014) to 13.2%. Contributors to this drop include state tobacco control policies, programs and services from multiple agencies and associations, and EndTobacco activities that complement the statewide effort to prevent youth smoking initiation and increase quit attempts among youth and adults.


Subject(s)
Neoplasms , Tobacco Use Disorder , Adult , Adolescent , United States/epidemiology , Humans , National Cancer Institute (U.S.) , Tobacco Use Disorder/prevention & control , Smoking , Nicotiana , Delivery of Health Care , Neoplasms/epidemiology , Neoplasms/prevention & control
19.
Rev. APS ; 25(Supl. 2): 160-181, 16/08/2022.
Article in Portuguese | LILACS | ID: biblio-1393282

ABSTRACT

No Brasil, a prevalência de tabagismo ainda é elevada em pessoas portadoras de Condições Crônicas não Transmissíveis (CCNT). A compreensão dos modelos de atenção ao tabagista é essencial para se reduzir o abandono do tratamento. Objetivos: identificar as características sociodemográficas e de saúde dos indivíduos que buscaram o Programa Nacional de Controle do Tabaco (PNCT) em duas Unidades Básicas de Saúde (UBS) do município de Campinas, estimar o percentual de abandono do tratamento e elencar os fatores associados a esse desfecho. Metodologia: coorte histórico cujos dados foram obtidos, entre 2016 e 2019, em grupos de tratamento do PNCT. Para a realização da análise exploratória, a pesquisa incluiu 276 participantes, dos quais foram registradas suas variáveis sociodemográficas, condições de saúde, formas de uso do tabaco e participação no programa. Foram estimados o índice de abandono do tratamento e as possíveis relações com as variáveis significativas através de regressão múltipla. Resultados: a média de idade foi de 50,7 anos, com 60% do sexo feminino, 57,7% brancos, 52,2% com companheiro, 84,7% com filhos, 52,5% com ensino fundamental, 64% com renda entre um e dois salários, 40,1% trabalhando em setor de serviços e 58% católicos. O percentual de abandono do tratamento foi de 31%. A hipertensão se relacionou com o abandono do tratamento (p=0,030), reduzindo-o. Conclusão: o perfil dos indivíduos foi semelhante ao encontrado em outras pesquisas; indivíduos não hipertensos apresentaram maioríndice de abandono. São necessários outros estudos que avaliem fatores associados ao abandono do tratamento


In Brazil, there is still a high prevalence of smoking among people with chronic diseases. The understanding of smoking treatments is essential to a reduction in treatment dropout. Objectives: to identify epidemiological and health aspects of smokers, estimate the dropout rates, and list the factorsassociated with treatment dropouts. Data from PNCT (National Program of Tobacco Control) treatment groups was obtained from a historical cohort between 2016 and 2019. The research included 276 participants with different sociodemographic realities, healthconditions, forms of tobacco use, and participation in the program to conduct an exploratory analysis. The treatment dropout rate and possible relations with significant variables were estimated through multiple regression. Results: The mean age was 50.7 years; 60% female; 57.7% white; 52.2% with a partner; 84.7% with children; 52.5% studied until elementary school; 64% received between one and two salaries; 40.1% worked in the service sector; 58% were Catholic. The percentage of treatment dropouts was 31%. Hypertension was related to treatment dropout (p = 0.030), reducing it. Conclusion: The profiles of individuals were similar to those in other surveys. Non-hypertensive individuals had a higher dropout rate. Further studies are needed to assess the factors associated with treatment dropout.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Patient Dropouts/statistics & numerical data , Tobacco Use Disorder/prevention & control , Smoking Prevention , Health Status , Risk Factors , Sociodemographic Factors
20.
Clin Pediatr (Phila) ; 61(8): 535-541, 2022 09.
Article in English | MEDLINE | ID: mdl-35484841

ABSTRACT

This study determined the types of tobacco products used by caregivers who presented to infant well-child visits (WCVs), tobacco product use by other household members, and caregivers' readiness to quit. The Ohio Chapter of the American Academy of Pediatrics conducted a 10-month quality improvement collaborative to improve providers' tobacco screening and cessation counseling practices. A sub-analysis of the initial screenings was performed to determine types of tobacco products used and caregivers' readiness to quit. Fourteen practices (60 providers) participated, and 3972 initial screens were analyzed; 320 (8.1%) caregivers and 490 (12.4%) household members used tobacco products. Most smoking caregivers and household members exclusively used cigarettes (79% and 72%, respectively). There was no difference in caregiver intention to quit by tobacco type, yet 53% of smoking caregivers were ready to quit. Providers should provide screening and cessation counseling to caregivers of infants at WCVs since many are ready to quit.


Subject(s)
Electronic Nicotine Delivery Systems , Smoking Cessation , Tobacco Products , Tobacco Use Disorder , Caregivers , Child , Humans , Infant , Infant, Newborn , Primary Health Care , Tobacco Use Disorder/prevention & control , Tobacco Use Disorder/psychology
SELECTION OF CITATIONS
SEARCH DETAIL